Teleflex (NYSE:TFX – Get Free Report) is anticipated to release its Q3 2026 results before the market opens on Thursday, October 29th. Analysts expect the company to post earnings of $1.90 per share and revenue of $565.51 million for the quarter. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. Parties may visit the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:00 AM ET.
Teleflex (NYSE:TFX – Get Free Report) last issued its earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.48. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%. The firm had revenue of $570.33 million for the quarter, compared to analyst estimates of $559.59 million. During the same period in the previous year, the company posted $3.73 earnings per share. The business’s revenue was up 28.9% on a year-over-year basis. On average, analysts expect Teleflex to post $7.22 EPS for the current fiscal year and $10.89 EPS for the next fiscal year.
Teleflex Stock Down 0.5%
Shares of NYSE TFX opened at $130.47 on Thursday. Teleflex has a one year low of $100.18 and a one year high of $145.00. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.60 and a quick ratio of 2.12. The business’s fifty day moving average price is $130.95 and its 200-day moving average price is $130.62. The stock has a market capitalization of $5.53 billion, a PE ratio of -5.60, a P/E/G ratio of 0.88 and a beta of 0.83.
Teleflex Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Friday, August 14th were issued a $0.34 dividend. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.36 annualized dividend and a yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is -5.84%.
Analyst Ratings Changes
Several brokerages recently weighed in on TFX. UBS Group lifted their price objective on Teleflex from $145.00 to $158.00 and gave the stock a “neutral” rating in a report on Tuesday, August 11th. Wall Street Zen raised shares of Teleflex from a “sell” rating to a “hold” rating in a report on Sunday, August 9th. Mizuho increased their target price on shares of Teleflex from $140.00 to $145.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 15th. Weiss Ratings reiterated a “sell (d)” rating on shares of Teleflex in a research report on Monday, September 21st. Finally, Bank of America upgraded shares of Teleflex from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $145.00 to $158.00 in a research note on Monday, September 28th. Two equities research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Teleflex presently has an average rating of “Moderate Buy” and an average target price of $154.40.
View Our Latest Research Report on Teleflex
About Teleflex
Teleflex Incorporated is a global medical technology company that develops, manufactures and markets specialty medical devices. Its products are designed to support healthcare professionals in critical care and procedural settings, including vascular access, interventional cardiology and radiology, anesthesia, respiratory care, emergency medicine, surgical applications and urology.
The company’s portfolio includes catheters, access and closure devices, airway-management products, surgical instruments, pain-management devices and other technologies used in hospitals and outpatient facilities.
Read More
- Five stocks we like better than Teleflex
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
